ACE2 and pulmonary fibrosis: AngII has been reported to significantly promote pulmonary fibrosis progression, and ACE2 obtains large amounts of AngII by hydrolyzing Ang-(1–7) to reduce local aggregation of pro-fibrotic factors in fibrotic lesions and thus inhibit the progression of pulmonary fibrosis [23].